| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3419145 | Revista Iberoamericana de Micología | 2009 | 12 Pages |
Abstract
The pharmacodynamic and pharmacokinetic profiles of micafungin imply that this drug is a safe alternative for the treatment of fungal infections. Micafungin can be safely co-administered with most drugs without the need for dosage adaptation even in patients with renal o liver function impairment.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Mercedes Catalán-González, Juan Carlos Montejo-González,